NVCT
NASDAQ
$18.03
Nuvectis Pharma Inc (NVCT)
Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $31.80 (+76.37%)
Market Cap
$520M
Free Cash Flow Yield
-3.53%
Beta (5Y)
0.93
Price Chart
Valuation
Market Cap$520M
P/B40.55
Profitability
EBITDA-$27M
EPS-$1.07
Financial Health
Free Cash Flow Yield-3.53%
Growth & Risk
Beta (5Y)0.93
Sharpe Ratio1.36